Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2091
Changes in Analgesic Prescriptions for the Treatment of Osteoarthritis During the COVID-19 Pandemic
Osteoarthritis – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 2334
Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS)
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2374
Characteristics, Treatment Responses and Prognosis in a Single Center Cohort of SLE Patients with Thrombocytopenia
SLE – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2308
Characterization of Damage in a Primary Sjogren’s Syndrome Cohort
Sjögren's Syndrome – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1827
Characterization of Fibroblast Subpopulations and Their Cellular Local Environments in Systemic Sclerosis Using Imaging Mass Cytometry
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1771
Characterization of Pathogenic Immune Mechanisms in Oligoarticular Juvenile Idiopathic Arthritis Applying Single-cell Transcriptomics and Proteomics
Pediatric Rheumatology – Basic Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2436
Characterization of RO7507062, a CD19-Targeting T-Cell Bispecific Antibody (CD19TCB), and Design of Its Ongoing Phase 1 Trial in Systemic Lupus Erythematosus
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2283
Characterization of Second-Line Therapy After First Janus Kinase Inhibitor Use: Results from the CorEvitas RA Registry
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2502
Characterization of the Tissue Fibroblast Repertoire in IgG4-Related Ophthalmic Disease
Vasculitis – Non-ANCA-Associated & Related Disorders Poster III- 10:30AM-12:30PM
-
Abstract Number: 1848
Characterization of Treg Phenotype, Function and Its Transcriptome Signatures in Treatment-naïve Rheumatoid Arthritis
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 1797
Characterizing Memory T Cell Subsets Associated with SLE Etiopathogenesis
SLE – Etiology & Pathogenesis Poster- 10:30AM-12:30PM
-
Abstract Number: 2380
Characterizing SLE Patients into Type 1 and Type 2 Disease States: Insights from a Single Lupus Cohort
SLE – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2415
Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network